Alliance Pharma PLC
LSE:APH
Alliance Pharma PLC
Net Income (Common)
Alliance Pharma PLC
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
A
|
Alliance Pharma PLC
LSE:APH
|
Net Income (Common)
-£7.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
GlaxoSmithKline PLC
LSE:GSK
|
Net Income (Common)
£4.9B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-1%
|
|
AstraZeneca PLC
LSE:AZN
|
Net Income (Common)
$6B
|
CAGR 3-Years
23%
|
CAGR 5-Years
23%
|
CAGR 10-Years
9%
|
|
Indivior PLC
LSE:INDV
|
Net Income (Common)
$2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-63%
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Net Income (Common)
$190m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-1%
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Net Income (Common)
-£27.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Alliance Pharma PLC's Net Income (Common)?
Net Income (Common)
-7.1m
GBP
Based on the financial report for Jun 30, 2023, Alliance Pharma PLC's Net Income (Common) amounts to -7.1m GBP.